Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.13 | -17.50 |
| PEG Ratio (TTM) | 0.07 | -5.53 |
| P/S Ratio (TTM) | 0.60 | 34.44 |
| P/B Ratio (TTM) | 0.89 | 5.76 |
| P/FCF Ratio (TTM) | -3.94 | -146.44 |
| Price to 5YR AVG Earnings Ratio | N/A | -34.29 |
| Price to 5YR AVG FCF Ratio | N/A | -1.09 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.16% | 287.39% |
| ROE (TTM) | -16.22% | -4,212.65% |
| Net Profit Margin (TTM) | -9.61% | -1,034.52% |
| ROIC 5YR AVG | N/A | -16.31% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1,722.86% | -5,764.75% | N/A |
| Revenue | -30.27% | N/A | N/A |
| Net Income | -1,401.04% | -7,337.69% | N/A |
| Cash Flow | -1,284.29% | -10,283.98% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.96 | 4.93 |
| Quick Ratio (TTM) | 1.64 | 4.91 |
| D/E Ratio (TTM) | 0.54 | 1.27 |
| Interest Coverage (TTM) | -2.19 | -11.12 |
| Piotroski F-Score | 3 | 3 |
| Altman Z-Score | 1.16 | 20.75 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 621.48% |